CAM
CSBR icon

ClariVest Asset Management’s Champions Oncology CSBR Stock Holding History

ClariVest Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-48,200
Closed -$386K – 698
2022
Q2 		$386K Hold
48,200
– – 0.02% 410
2022
Q1 		$392K Sell
48,200
-7,200
-13% -$57.7K 0.02% 418
2021
Q4 		$463K Sell
55,400
-900
-2% -$8.29K 0.01% 442
2021
Q3 		$575K Sell
56,300
-300
-0.5% -$3.05K 0.02% 422
2021
Q2 		$582K Hold
56,600
– – 0.02% 412
2021
Q1 		$640K Buy
56,600
+3,000
+6% +$34.8K 0.02% 372
2020
Q4 		$579K Sell
53,600
-600
-1% -$6.19K 0.02% 353
2020
Q3 		$501K Sell
54,200
-3,400
-6% -$30.3K 0.02% 356
2020
Q2 		$551K Sell
57,600
-3,300
-5% -$28.1K 0.02% 390
2020
Q1 		$450K Sell
60,900
-3,700
-6% -$25.9K 0.01% 409
2019
Q4 		$538K Buy
64,600
+23,200
+56% +$143K 0.01% 419
2019
Q3 		$234K Sell
41,400
-400
-1% -$2.6K 0.01% 482
2019
Q2 		$327K Sell
41,800
-600
-1% -$5.26K 0.01% 402
2019
Q1 		$415K Buy
42,400
+2,600
+7% +$25.9K 0.01% 470
2018
Q4 		$311K Buy
39,800
+9,100
+30% +$105K 0.01% 493
2018
Q3 		$536K Buy
+30,700
New +$273K 0.01% 493

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClariVest Asset Management's CSBR Position: Q3 2022 in Review

ClariVest Asset Management sold out of Champions Oncology (CSBR) in Q3 2022, closing a stake of 48,200 shares — an estimated $386K sold.

ClariVest Asset Management first reported a position in CSBR in Q3 2018 and held it in 16 quarters. The position peaked at $640K in Q1 2021. 32 funds tracked by Wall St. Rank hold CSBR as of Q3 2022.

  • ClariVest Asset Management reported no remaining Champions Oncology position as of Q3 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 48,200 Champions Oncology shares in Q3 2022, an estimated $386K.
  • ClariVest Asset Management first reported a position in Champions Oncology in Q3 2018 and held it in 16 quarters.
  • ClariVest Asset Management's Champions Oncology position peaked at $640K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2022.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.